Accuracy Coverage Pricing Contact
Quest Diagnostics, Inc.

Quest Diagnostics, Inc. (DGX)

Quest Diagnostics Incorporated, incorporated on September 20, 1996, is a provider of diagnostic information services. The Company operates through two businesses: Diagnostic Information Services and Diagnostic Solutions. The Diagnostic Information Services business develops and delivers diagnostic testing information and services, providing insights that empower and enable a range of customers, including patients, clinicians, hospitals, integrated delivery networks (IDNs), health plans, employers and accountable care organizations (ACOs). Its Diagnostic Solutions group includes its risk assessment services business, which offers solutions for insurers, and its healthcare information technology businesses, which offers solutions for healthcare providers.

Diagnostic Information Services

The Company provides information and insights based on routine, non-routine and advanced clinical testing and anatomic pathology testing, and related services, offering customers the test menu. The Company offers testing solutions, including services for the predisposition, diagnosis, treatment and monitoring of cancers and other diseases, and offer tests in various fields, including endocrinology, immunology, neurology and oncology. It is focused on providing solutions and insights to its customers, based on the testing that it performs and its medical, information and connectivity assets. It provides integrated, diagnostic information services that include both anatomic pathology and clinical laboratory testing, enabling it to offer patients and clinicians a complete analysis. The Company offers access in the United States to diagnostic information services through its nationwide network of laboratories, patient service centers, and phlebotomists in physician offices. It provides interpretive consultation through medical and scientific staffs in the industry.

The Company is a provider of infectious disease diagnostic information services. It also provides diagnostic solutions for infectious diseases, including its Focus Diagnostics offerings for Zika, West Nile Virus, Severe acute respiratory syndrome (SARS) and Influenza A H1N1. It is engaged in the neurology diagnostics market, in cardiovascular diagnostic information services, including its CardioIQ offering, and in cancer diagnostics, including its QuestVantage offerings. It is engaged in providing testing for the detection of employee use of drugs of abuse, offering a range of solutions, including urine, hair, blood and oral fluid tests. The Company is a provider of biometric wellness screenings, flu shots and related preventative services. It offers biometric wellness screenings to employer populations through its patient service centers and on-site through its network of mobile examiners and nurses. In addition to a range of screening options, it also offers Blueprint for Wellness and private label reporting, analytics and incentive management services. These services are sold directly to employers and through reseller partnerships with various health plans.

The Company's Quanum health information technology solutions help healthcare organizations and clinicians empower health through diagnostic insights by taking advantage of its information assets, including various years of test result data, and its technology prowess, including its history of providing information technology for diagnostic information services. It provides diagnostic information services in various markets outside the United States. It has laboratory facilities in Gurgaon, India; Mexico City, Mexico, and San Juan, Puerto Rico. It also provides testing services, and inpatient anatomic pathology and medical director services, at hospital laboratories. Its services primarily are provided under the Quest Diagnostics brand, but it also provides services under other brands, including AmeriPath, Dermpath Diagnostics, Focus Diagnostics, Athena Diagnostics, ExamOne, Quanum and Care360.

Diagnostic Solutions

The Company is a provider of risk assessment services for the life insurance industry. In addition, it offers healthcare organizations and clinicians health information technology solutions. ExamOne is a provider of risk assessment services to the life insurance industry in North America. It also provides risk assessment services for insurance companies operating outside North America. Its risk assessment services comprise underwriting support services, including data gathering, paramedical examinations and clinical laboratory testing and analytics, designed to assist life insurance companies objectively to evaluate the mortality risks of applicants. As of December 31, 2016, specimen collections and paramedical examinations were performed by its network of paramedical examiners at the applicant's home or workplace, but they also were offered at approximately 600 company patient service centers in the United States and approximately 120 additional locations in North America.

The Company's healthcare information technology offerings include its Quanum EHR product and its ChartMaxx enterprise content management system for hospitals. Its Quanum EHR offering enables clinicians to generate a complete record of a clinical patient encounter, automates and streamlines the clinician's workflow, provides clinical decision support tools, captures patient encounter notes and lab and radiology results and enables communication with patients and other clinicians. Its MyQuest patient healthcare portal enables patients to manage their healthcare and medical information and, among other things, use their smartphone or computer to receive and archive their Quest Diagnostics test results, find a Quest Diagnostics location and schedule appointments.

The Company competes with Laboratory Corporation of America Holdings, Inc.

Fundamentals

Optimized Dividends

Annual Dividends

Year Amount Change
2006 0.0c
2007 0.0c 0%
2008 0.0c 0%
2009 0.0c 0%
2010 0.0c 0%
2011 17.0c 100%
2012 81.0c 376.5%
2013 120.0c 48.1%
2014 132.0c 10.0%
2015 152.0c 15.2%
2016 165.0c 8.6%
2017 180.0c 9.1%
2018 203.0c 12.8%
2019 Login required
2020 Login required
2021 Login required

Dividends

Ex-Div Date Pay Date Year Type Frequency Status Amount
05 Jan 2012 24 Jan 2012 2011 Final Quarterly Paid 17c
30 Mar 2012 17 Apr 2012 2012 Interim Quarterly Paid 17c
29 Jun 2012 18 Jul 2012 2012 Interim Quarterly Paid 17c
27 Sep 2012 16 Oct 2012 2012 Interim Quarterly Paid 17c
09 Jan 2013 28 Jan 2013 2012 Final Quarterly Paid 30c
28 Mar 2013 16 Apr 2013 2013 Interim Quarterly Paid 30c
28 Jun 2013 17 Jul 2013 2013 Interim Quarterly Paid 30c
27 Sep 2013 16 Oct 2013 2013 Interim Quarterly Paid 30c
03 Jan 2014 22 Jan 2014 2013 Final Quarterly Paid 30c
04 Apr 2014 23 Apr 2014 2014 Interim Quarterly Paid 33c
07 Jul 2014 23 Jul 2014 2014 Interim Quarterly Paid 33c
03 Oct 2014 22 Oct 2014 2014 Interim Quarterly Paid 33c
09 Jan 2015 28 Jan 2015 2014 Final Quarterly Paid 33c
06 Apr 2015 22 Apr 2015 2015 Interim Quarterly Paid 38c
06 Jul 2015 22 Jul 2015 2015 Interim Quarterly Paid 38c
02 Oct 2015 21 Oct 2015 2015 Interim Quarterly Paid 38c
08 Jan 2016 27 Jan 2016 2015 Final Quarterly Paid 38c
04 Apr 2016 20 Apr 2016 2016 Interim Quarterly Paid 40c
01 Jul 2016 20 Jul 2016 2016 Interim Quarterly Paid 40c
30 Sep 2016 19 Oct 2016 2016 Interim Quarterly Paid 40c
06 Jan 2017 25 Jan 2017 2016 Final Quarterly Paid 45c
03 Apr 2017 19 Apr 2017 2017 Interim Quarterly Paid 45c
06 Jul 2017 24 Jul 2017 2017 Interim Quarterly Paid 45c
02 Oct 2017 18 Oct 2017 2017 Interim Quarterly Paid 45c
08 Jan 2018 24 Jan 2018 2017 Final Quarterly Paid 45c
03 Apr 2018 18 Apr 2018 2018 Interim Quarterly Paid 50c
06 Jul 2018 23 Jul 2018 2018 Interim Quarterly Paid 50c
04 Oct 2018 22 Oct 2018 2018 Interim Quarterly Paid 50c
14 Jan 2019 30 Jan 2019 2018 Final Quarterly Paid 53c
05 Apr 2019 22 Apr 2019 2019 Interim Quarterly Paid 53c
05 Jul 2019 22 Jul 2019 2019 Interim Quarterly Paid 53c
Login Login 2019 Interim Quarterly Declared Login
Login Login 2019 Final Quarterly Forecast Login
Login Login 2020 Interim Quarterly Forecast Login
Login Login 2020 Interim Quarterly Forecast Login
Login Login 2020 Interim Quarterly Forecast Login
Login Login 2020 Final Quarterly Forecast Login
Login Login 2021 Interim Quarterly Forecast Login
Login Login 2021 Interim Quarterly Forecast Login
Login Login 2021 Interim Quarterly Forecast Login
Login Login 2021 Final Quarterly Forecast Login

Quest Diagnostics, Inc. optimized dividend - 12 month history

Optimized dividend graph demo

Quest Diagnostics, Inc. share price - 12 month history

You're currently viewing outdated and/or artificial data.

Try the real thing now:

Activate Free Trial